Soren Nielsen
Chief Executive Officer at Reponex Pharmaceuticals A/S
Soren Nielsen active positions
| Companies | Position | Start | End |
|---|---|---|---|
AKI Therapeutics ApS
 AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016. | Director/Board Member | - | - |
Reponex Pharmaceuticals A/S
 Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million. | Chief Executive Officer | - | - |
Career history of Soren Nielsen
Statistics
International
| Denmark | 3 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
AKI Therapeutics ApS
AKI Therapeutics ApS Pharmaceuticals: MajorHealth Technology AKI Therapeutics ApS is a Danish pharmaceutical company that manufactures pharmaceutical products. The private company is based in Hørsholm, Denmark and was founded in 2016. | Health Technology |
Reponex Pharmaceuticals A/S
Reponex Pharmaceuticals A/S BiotechnologyHealth Technology Part of Pharma Equity Group A/S, Reponex Pharmaceuticals A/S operates as a Danish clinical stage biopharmaceutical company. The company is based in Hørsholm, Denmark. The company was founded in 2006. The CEO is Soren Nielsen. Reponex Pharmaceuticals was acquired by Pharma Equity Group A/S on March 24, 2023 for $109.83 million. | Health Technology |
- Stock Market
- Insiders
- Soren Nielsen
- Experience
